Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 316–317 (2006)Cite this article

boxed-textGonzalez-Peralta RP et al. (2005) Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety and pharmacokinetics. Hepatology 42: 1010–1018

Combined therapy with interferon-α2b plus ribavirin seems effective for the treatment of children with chronic hepatitis C; however, better results might be obtained using pegylated interferon-α2b plus ribavirin

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wirth S et al. (2002) Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36: 1280–1284

    Article  CAS  Google Scholar 

  2. Kowala-Piaskowska A et al. (2005) Factors influencing early virological response in children with chronic viral hepatitis C treated with pegylated interferon and ribavirin. Hepatol Res 32: 224–226

    CAS  PubMed  Google Scholar 

  3. Manns MP et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358: 958–9654

    Article  CAS  Google Scholar 

  4. Mozer-Lisewska I et al. (2003) Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C. Eur J Pediatr 162: 755–759

    Article  CAS  Google Scholar 

  5. Bruno S et al. (2004) Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial. J Hepatol 41: 474–481

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Deputy Head of the Department of Infectious Diseases and Child Neurology at the University of Medical Sciences, Poznań, Poland

    Iwona Mozer-Lisewska

Authors
  1. Iwona Mozer-Lisewska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iwona Mozer-Lisewska.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mozer-Lisewska, I. Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C. Nat Rev Gastroenterol Hepatol 3, 316–317 (2006). https://doi.org/10.1038/ncpgasthep0495

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0495

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing